KAREN POPP: Open Payments
NPI 1588744791 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 15 payments from 9 companies in 2025. Trend: 2023 $271 · 2024 $209 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $85 |
| ABIOMED | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 1 | $24 |
| Abbott Laboratories | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, NURTEC ODT, Wegovy, MOUNJARO, FREESTYLE LIBRE 3, UBRELVY, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
